Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dysphagia and multiple sclerosis.

M Prosiegel1, A Schelling, E Wagner-Sonntag

  • 1Neurologisches Krankenhaus München (NKM), Tristanstrasse 20, D-80804 Munich, Germany. prosiegel-nkm@t-online.de

International MS Journal
|May 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Management of dysphagia in acute stroke : A prospective study for validation of current recommendations].

Der Nervenarzt·2017
Same author

[FEES for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German Stroke Society].

Der Nervenarzt·2014
Same author

Long-term functional outcome in patients with neurogenic dysphagia.

NeuroRehabilitation·2014
Same author

[FEES in the stroke unit: recommendations for implementation in the clinical routine].

Der Nervenarzt·2013
Same author

[Management of dysphagic patients with acute stroke].

Der Nervenarzt·2012
Same author

Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept.

Journal of neurology·2010
Same journal

American academy of neurology annual meeting.

International MS journal·2011
Same journal

Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.

International MS journal·2011
Same journal

The clinical usefulness of routine MRI assessment.

International MS journal·2011
Same journal

Acute Psychosis as the Initial Presentation of MS: A Case Report.

International MS journal·2011
Same journal

Russell Brains Review of MS.

International MS journal·2011
Same journal

Epstein-Barr Virus and MS:Causality or Association?

International MS journal·2011
See all related articles

More than 30% of people with multiple sclerosis experience swallowing problems, known as neurogenic dysphagia. Early diagnosis and functional swallowing therapy are crucial for preventing aspiration pneumonia.

Area of Science:

  • Neurology
  • Gastroenterology
  • Speech-Language Pathology

Background:

  • Swallowing difficulties (dysphagia) affect over 30% of persons with multiple sclerosis (pwMS), a higher prevalence than previously recognized.
  • Neurogenic dysphagia in pwMS stems from oropharyngeal sensorimotor dysfunctions, correlating with disability levels and brainstem signs.
  • Even pwMS with mild disability have a significant risk (approximately 15%) of developing neurogenic dysphagia.

Purpose of the Study:

  • To highlight the prevalence and impact of neurogenic dysphagia in pwMS.
  • To outline current diagnostic approaches for neurogenic dysphagia.
  • To emphasize the goals and methods of intervention and outcome assessment for dysphagia in pwMS.

Main Methods:

  • Clinical assessment including history taking and bedside screening (e.g., 50 ml water test, pharyngeal sensation assessment, pulse oximetry).

Related Experiment Videos

  • Instrumental evaluations such as videofluoroscopic swallowing study (VFSS) and fibreoptic endoscopic evaluation of swallowing (FEES) as complementary diagnostic tools.
  • Review of functional swallowing therapies (restitution, compensation, adaptation) and outcome measures focusing on activity limitation, participation restriction, and quality of life.

    • Main Results:

    • Neurogenic dysphagia is a common complication in pwMS, impacting those with varying degrees of disability.
    • A combination of clinical and instrumental methods is used for diagnosis, with VFSS and FEES offering distinct advantages.
    • Functional swallowing therapy aims to prevent aspiration and aspiration pneumonia.

    Conclusions:

    • Neurogenic dysphagia is highly prevalent in pwMS and requires thorough assessment.
    • Diagnostic tools range from bedside tests to advanced imaging, each with specific benefits.
    • Effective interventions focus on functional swallowing rehabilitation and patient-centered outcomes to improve quality of life.